RU2762279C2 - Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы - Google Patents
Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы Download PDFInfo
- Publication number
- RU2762279C2 RU2762279C2 RU2019121006A RU2019121006A RU2762279C2 RU 2762279 C2 RU2762279 C2 RU 2762279C2 RU 2019121006 A RU2019121006 A RU 2019121006A RU 2019121006 A RU2019121006 A RU 2019121006A RU 2762279 C2 RU2762279 C2 RU 2762279C2
- Authority
- RU
- Russia
- Prior art keywords
- tetrahydropyran
- ethyl
- pyrazolo
- dihydro
- oxospiro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2016/080548 WO2018108230A1 (en) | 2016-12-12 | 2016-12-12 | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019121006A3 RU2019121006A3 (cg-RX-API-DMAC7.html) | 2021-01-12 |
| RU2019121006A RU2019121006A (ru) | 2021-01-12 |
| RU2762279C2 true RU2762279C2 (ru) | 2021-12-17 |
Family
ID=57539258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019121006A RU2762279C2 (ru) | 2016-12-12 | 2016-12-12 | Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10906915B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3551633B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6850886B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110088108B (cg-RX-API-DMAC7.html) |
| DK (1) | DK3551633T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2875128T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2762279C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018108230A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11065257B2 (en) * | 2016-12-12 | 2021-07-20 | Leo Pharma A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
| AU2018286964B2 (en) | 2017-06-20 | 2022-04-14 | UNION therapeutics A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| WO2019115776A1 (en) | 2017-12-15 | 2019-06-20 | Leo Pharma A/S | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors |
| GB202306662D0 (en) | 2023-05-05 | 2023-06-21 | Union Therapeutics As | Dosage regimen |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005071B1 (ru) * | 2000-01-05 | 2004-10-28 | Уорнер-Ламберт Компани | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ |
| WO2007040435A1 (en) * | 2005-10-03 | 2007-04-12 | Astrazeneca Ab | Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| WO2008104175A2 (en) * | 2007-02-28 | 2008-09-04 | Leo Pharma A/S | Novel phosphodiesterase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7423031B2 (en) | 2003-05-01 | 2008-09-09 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| CA2669886A1 (en) | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
| GB0704652D0 (en) | 2007-03-09 | 2007-04-18 | Syngenta Participations Ag | Novel herbicides |
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
-
2016
- 2016-12-12 CN CN201680091502.7A patent/CN110088108B/zh not_active Expired - Fee Related
- 2016-12-12 RU RU2019121006A patent/RU2762279C2/ru active
- 2016-12-12 ES ES16809388T patent/ES2875128T3/es active Active
- 2016-12-12 US US16/468,420 patent/US10906915B2/en active Active
- 2016-12-12 JP JP2019531209A patent/JP6850886B2/ja not_active Expired - Fee Related
- 2016-12-12 WO PCT/EP2016/080548 patent/WO2018108230A1/en not_active Ceased
- 2016-12-12 EP EP16809388.8A patent/EP3551633B1/en active Active
- 2016-12-12 DK DK16809388.8T patent/DK3551633T3/da active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005071B1 (ru) * | 2000-01-05 | 2004-10-28 | Уорнер-Ламберт Компани | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ |
| WO2007040435A1 (en) * | 2005-10-03 | 2007-04-12 | Astrazeneca Ab | Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| WO2008104175A2 (en) * | 2007-02-28 | 2008-09-04 | Leo Pharma A/S | Novel phosphodiesterase inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019121006A3 (cg-RX-API-DMAC7.html) | 2021-01-12 |
| DK3551633T3 (da) | 2021-06-28 |
| US10906915B2 (en) | 2021-02-02 |
| ES2875128T3 (es) | 2021-11-08 |
| US20200010477A1 (en) | 2020-01-09 |
| JP6850886B2 (ja) | 2021-03-31 |
| EP3551633A1 (en) | 2019-10-16 |
| CN110088108B (zh) | 2024-06-14 |
| JP2020500920A (ja) | 2020-01-16 |
| EP3551633B1 (en) | 2021-03-31 |
| WO2018108230A1 (en) | 2018-06-21 |
| CN110088108A (zh) | 2019-08-02 |
| RU2019121006A (ru) | 2021-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2583787C2 (ru) | Гетероциклические соединения бензодиоксола или бензодиоксепина в качестве ингибиторов фосфодиэстераз | |
| JP7198820B2 (ja) | 置換アゼチジンジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用 | |
| JP7201688B2 (ja) | 置換テトラヒドロピランジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用 | |
| CA2931732A1 (en) | Substituted benzamides and methods of use thereof | |
| EP3724196B9 (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| CN111108109A (zh) | 取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途 | |
| JP6850886B2 (ja) | 置換ピラゾロアゼピン−4−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 | |
| CN104011048B (zh) | 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用 | |
| JP7008073B2 (ja) | 置換ピラゾロアゼピン-4-オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 | |
| RU2764273C2 (ru) | Замещенные пиразолоазепин-8-оны и их применение в качестве ингибиторов фосфодиэстеразы | |
| HK40041147B (en) | Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | |
| HK40041147A (en) | Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | |
| HK40039957B (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant |